Riopan 800 mg
Riopan 800 mg is a medicine authorised by Swissmedic under authorisation number 46516. The authorisation holder is Takeda Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 15 November 1985 and the authorisation is valid without a time limit. ATC code A02AD02 places the medicine in the group Drugs for acid related disorders.
| Authorisation number | 46516 |
|---|---|
| Name | Riopan 800 mg |
| Full name | Riopan 800 mg, Tabletten |
| Authorisation holder | Takeda Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | A02AD02 |
| First authorisation | 15 November 1985 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Riopan 800 mg, Tabletten | D | 15 November 1985 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 28 | 50 | Tablette(n) | A02AD02 | 04.01.0. | D |
| 36 | 100 | Tablette(n) | A02AD02 | 04.01.0. | D |
| 44 | 20 | Tablette(n) | A02AD02 | 04.01.0. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Riopan 800 mg authorised in Switzerland?
Yes. Riopan 800 mg is authorised by Swissmedic under authorisation number 46516, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Riopan 800 mg have?
Riopan 800 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Riopan 800 mg?
The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.